Boothe P, Kumar V, Kong Y, Wang K, Levinson H, Mu D
Int J Mol Sci. 2024; 25(15).
PMID: 39125831
PMC: 11312688.
DOI: 10.3390/ijms25158261.
Song J, Xia Y, Yan X, Luo J, Jiang C, Zhang M
Int Urol Nephrol. 2019; 51(11):2073-2081.
PMID: 31401712
DOI: 10.1007/s11255-019-02253-8.
Noureddin M, Zhang A, Loomba R
Expert Opin Emerg Drugs. 2016; 21(3):343-57.
PMID: 27501374
PMC: 5906104.
DOI: 10.1080/14728214.2016.1220533.
Zhu Q, Li N, Li F, Zhou Z, Han Q, Lv Y
J Renin Angiotensin Aldosterone Syst. 2016; 17(1):1470320316628717.
PMID: 27009285
PMC: 5843853.
DOI: 10.1177/1470320316628717.
Zhang Y, Zhou N, Wang H, Wang S, He J
Exp Ther Med. 2015; 9(6):2034-2042.
PMID: 26136932
PMC: 4473336.
DOI: 10.3892/etm.2015.2383.
RhoA/Rho kinase mediates TGF-β1-induced kidney myofibroblast activation through Poldip2/Nox4-derived reactive oxygen species.
Manickam N, Patel M, Griendling K, Gorin Y, Barnes J
Am J Physiol Renal Physiol. 2014; 307(2):F159-71.
PMID: 24872317
PMC: 4101629.
DOI: 10.1152/ajprenal.00546.2013.
Grape seed extract attenuates arsenic-induced nephrotoxicity in rats.
Zhang J, Pan X, Li N, Li X, Wang Y, Liu X
Exp Ther Med. 2013; 7(1):260-266.
PMID: 24348802
PMC: 3861237.
DOI: 10.3892/etm.2013.1381.
A nonclassical vitamin D receptor pathway suppresses renal fibrosis.
Ito I, Waku T, Aoki M, Abe R, Nagai Y, Watanabe T
J Clin Invest. 2013; 123(11):4579-94.
PMID: 24135137
PMC: 3809783.
DOI: 10.1172/JCI67804.
Expression of angiotensinogen during hepatic fibrogenesis and its effect on hepatic stellate cells.
Lu P, Liu H, Yin H, Yang L
Med Sci Monit. 2011; 17(9):BR248-56.
PMID: 21873937
PMC: 3560510.
DOI: 10.12659/msm.881928.
Effects of 1-year administration of olmesartan on portal pressure and TGF-beta1 in selected patients with cirrhosis: a randomized controlled trial.
Hidaka H, Nakazawa T, Shibuya A, Minamino T, Takada J, Tanaka Y
J Gastroenterol. 2011; 46(11):1316-23.
PMID: 21850387
DOI: 10.1007/s00535-011-0449-z.
Combining angiotensin II blockade and renin receptor inhibition results in enhanced antifibrotic effect in experimental nephritis.
Zhang J, Gu C, Noble N, Border W, Huang Y
Am J Physiol Renal Physiol. 2011; 301(4):F723-32.
PMID: 21795644
PMC: 3191801.
DOI: 10.1152/ajprenal.00271.2011.
Myofibroblast differentiation during fibrosis: role of NAD(P)H oxidases.
Barnes J, Gorin Y
Kidney Int. 2011; 79(9):944-56.
PMID: 21307839
PMC: 3675765.
DOI: 10.1038/ki.2010.516.
Urinary transforming growth factor beta-1 as a marker of renal dysfunction in sickle cell disease.
Mohtat D, Thomas R, Du Z, Boakye Y, Moulton T, Driscoll C
Pediatr Nephrol. 2010; 26(2):275-80.
PMID: 21107986
DOI: 10.1007/s00467-010-1677-9.
Blockade of osteopontin inhibits glomerular fibrosis in a model of anti-glomerular basement membrane glomerulonephritis.
Zhou C, Wu J, Torres L, Hicks J, Bartkowiak T, Parker K
Am J Nephrol. 2010; 32(4):324-31.
PMID: 20720406
PMC: 2969149.
DOI: 10.1159/000319490.
Infusion of angiotensin-(1-7) reduces glomerulosclerosis through counteracting angiotensin II in experimental glomerulonephritis.
Zhang J, Noble N, Border W, Huang Y
Am J Physiol Renal Physiol. 2009; 298(3):F579-88.
PMID: 20032116
PMC: 2838590.
DOI: 10.1152/ajprenal.00548.2009.
NAD(P)H oxidase mediates TGF-beta1-induced activation of kidney myofibroblasts.
Bondi C, Manickam N, Lee D, Block K, Gorin Y, Abboud H
J Am Soc Nephrol. 2009; 21(1):93-102.
PMID: 19926889
PMC: 2799274.
DOI: 10.1681/ASN.2009020146.
Circulating TGF-beta1 as a reliable biomarker for chronic kidney disease progression in the African-American population.
Lee S, Kanasaki K, Kalluri R
Kidney Int. 2009; 76(1):10-2.
PMID: 19528989
PMC: 4313549.
DOI: 10.1038/ki.2009.130.
Effects of tanshinone IIA on transforming growth factor beta1-Smads signal pathway in renal interstitial fibroblasts of rats.
Tang J, Zhan C, Zhou J
J Huazhong Univ Sci Technolog Med Sci. 2008; 28(5):539-42.
PMID: 18846334
DOI: 10.1007/s11596-008-0511-0.
Mechanisms of progression of chronic kidney disease.
Fogo A
Pediatr Nephrol. 2007; 22(12):2011-22.
PMID: 17647026
PMC: 2064942.
DOI: 10.1007/s00467-007-0524-0.
Sustained renal interstitial macrophage infiltration following chronic angiotensin II infusions.
Ozawa Y, Kobori H, Suzaki Y, Navar L
Am J Physiol Renal Physiol. 2006; 292(1):F330-9.
PMID: 16804106
PMC: 2001287.
DOI: 10.1152/ajprenal.00059.2006.
